Laurence S. Freedman

Generating author description...

All published works

Action	Title	Year	Authors
+	Issues in Implementing Regression Calibration Analyses.	2023	Lillian Boe Pamela A. Shaw Douglas Midthune Paul Gustafson Victor Kipnis Eunyoung Park Daniela Sotres‐Alvarez Laurence S. Freedman On Behalf Of The Measurement Error And Misclassification Topic Group Tg Of The Stratos Initiative
+	Reverse causation biases weighted cumulative exposure model estimates, but can be investigated in sensitivity analyses	2023	Nirit Agay Rachel Dankner Havi Murad Liraz Olmer Laurence S. Freedman
+	The Impact of Reverse Causation on Estimates from a Cumulative Weighted Exposure Model and a Method of Adjustment	2023	Nirit Agay Rachel Dankner Havi Murad Liraz Olmer Laurence S. Freedman
+ PDF Chat	Similarity of Protection Conferred by Previous SARS-CoV-2 Infection and by BNT162b2 Vaccine: A 3-Month Nationwide Experience From Israel	2022	Yair Goldberg Micha Mandel Yonatan Woodbridge Ronen Fluss Ilya Novikov Rami Yaari Arnona Ziv Laurence S. Freedman Amit Huppert
+	Issues in Implementing Regression Calibration Analyses	2022	Lillian Boe Pamela A. Shaw Douglas Midthune Paul Gustafson Victor Kipnis Eun‐Young Park Daniela Sotres‐Alvarez Laurence S. Freedman
+	Protection and waning of natural and hybrid COVID-19 immunity	2021	Yair Goldberg Micha Mandel Yinon M. Bar-On Omri Bodenheimer Laurence S. Freedman Nachman Ash Sharon Alroy‐Preis Amit Huppert Ron Milo
+ PDF Chat	Waning Immunity after the BNT162b2 Vaccine in Israel	2021	Yair Goldberg Micha Mandel Yinon M. Bar-On Omri Bodenheimer Laurence S. Freedman Eric J. Haas Ron Milo Sharon Alroy‐Preis Nachman Ash Amit Huppert
+ PDF Chat	Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19	2021	Yinon M. Bar-On Yair Goldberg Micha Mandel Omri Bodenheimer Laurence S. Freedman Sharon Alroy‐Preis Nachman Ash Amit Huppert Ron Milo
+ PDF Chat	BNT162b2 vaccine booster dose protection: A nationwide study from Israel	2021	Yinon M. Bar-On Yair Goldberg Micha Mandel Omri Bodenheimer Laurence S. Freedman Nir Kalkstein Barak Mizrahi Sharon Alroy‐Preis Nachman Ash Ron Milo
+	Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel	2021	Yair Goldberg Micha Mandel Yonatan Woodbridge Ronen Fluss Ilya Novikov Rami Yaari Arnona Ziv Laurence S. Freedman Amit Huppert
+	BNT162b2 Vaccine-Induced Immune Responses and Dynamics Vary Among Age Groups, Sex and Co-Morbidities: A Longitudinal Prospective Cohort Study	2021	Yaniv Lustig Einav Sapir Gili Regev‐Yochay Carmit Cohen Ronen Fluss Liraz Olmer Victoria Indenbaum Michal Mandelboim Ram Doolman Sharon Amit
+	STRATOS guidance document on measurement error and misclassification of variables in observational epidemiology: Part 2—More complex methods of adjustment and advanced topics	2020	Pamela A. Shaw Paul Gustafson Raymond J. Carroll Veronika Deffner Kevin W. Dodd Ruth H. Keogh Victor Kipnis Janet A. Tooze Michael P. Wallace Helmut Küchenhoff
+	Imputing missing time-dependent covariate values for the discrete time Cox model	2019	Havi Murad Rachel Dankner A. Berlin Liraz Olmer Laurence S. Freedman
+	Berkson error in epidemiology (TG4)	2019	Laurence S. Freedman
+ PDF Chat	Epidemiologic analyses with error-prone exposures: review of current practice and recommendations	2018	Pamela A. Shaw Veronika Deffner Ruth H. Keogh Janet A. Tooze Kevin W. Dodd Helmut Küchenhoff Victor Kipnis Laurence S. Freedman
+ PDF Chat	Moment reconstruction and moment‐adjusted imputation when exposure is generated by a complex, nonlinear random effects modeling process	2016	Cornelis J. Potgieter Rubin Wei Victor Kipnis Laurence S. Freedman Raymond J. Carroll
+ PDF Chat	Measurement error models with interactions	2015	Douglas Midthune Raymond J. Carroll Laurence S. Freedman Victor Kipnis
+ PDF Chat	Correction — A statistical model for measurement error that incorporates variation over time in the target measure, with application to nutritional epidemiology	2015	Laurence S. Freedman
+	Estimation of infection prevalence and sensitivity in a stratified two-stage sampling design employing highly specific diagnostic tests when there is no gold standard	2015	Ezer Miller Amit Huppert Ilya Novikov Alon Warburg Asrat Hailu Ibrahim Abbasi Laurence S. Freedman
+	<scp>P</scp> ocock and <scp>S</scp> imon Method	2014	Laurence S. Freedman
+ PDF Chat	Regression calibration with more surrogates than mismeasured variables	2012	Victor Kipnis Douglas Midthune Laurence S. Freedman Raymond J. Carroll
+ PDF Chat	A new multivariate measurement error model with zero-inflated dietary data, and its application to dietary assessment	2011	Saijuan Zhang Raymond J. Carroll Douglas Midthune Patricia M. Guenther Susan M. Krebs‐Smith Victor Kipnis Kevin W. Dodd Dennis W. Buckman Janet A. Tooze Laurence S. Freedman
+ PDF Chat	A mixed‐effects model approach for estimating the distribution of usual intake of nutrients: The NCI method	2010	Janet A. Tooze Victor Kipnis Dennis W. Buckman Raymond J. Carroll Laurence S. Freedman Patricia M. Guenther Susan M. Krebs‐Smith Amy F. Subar Kevin W. Dodd
+ PDF Chat	A modified approach to estimating sample size for simple logistic regression with one continuous covariate	2009	Ilya Novikov Naama Fund Laurence S. Freedman
+	An analysis of the controversy over classical one-sided tests	2008	Laurence S. Freedman
+ PDF Chat	A comparison of regression calibration, moment reconstruction and imputation for adjusting for covariate measurement error in regression	2008	Laurence S. Freedman Douglas Midthune Raymond J. Carroll Victor Kipnis
+	Quantitative science methods for biomarker validation in chemoprevention trials	2007	Laurence S. Freedman
+	Estimating and testing interactions in linear regression models when explanatory variables are subject to classical measurement error	2007	Havi Murad Laurence S. Freedman
+	Linear Measurement Error Models with Restricted Sampling	2006	Malka Gorfine Nurit Lipshtat Laurence S. Freedman Ross L. Prentice
+	<scp>P</scp> ocock and <scp>S</scp> imon Method	2005	Laurence S. Freedman
+	Modification of the Computational Procedure in Parker and Bregman's Method of Calculating Sample Size from Matched Case–Control Studies with a Dichotomous Exposure	2005	Ilya Novikov Tsz‐Kwong Man Laurence S. Freedman
+	Report of the Co‐Editors – 2004	2005	B. R. Cullis Laurence S. Freedman Mike Kenward Xihong Lin
+	Commentary on Assessing surrogates as trial endpoints using mixed models by E. L. Korn, P. S. Albert and L. M. McShane	2005	Laurence S. Freedman
+	A New Method for Dealing with Measurement Error in Explanatory Variables of Regression Models	2004	Laurence S. Freedman Vitaly Fainberg Victor Kipnis Douglas Midthune Raymond J. Carroll
+ PDF Chat	Erratum to: A simple method for analyzing data from a randomized trial with a missing binary outcome	2004	Stuart G. Baker Laurence S. Freedman
+	Methodology of Randomized Trials	2004	Laurence S. Freedman
+	The analysis of the influence of birth order and other factors in multiple birth data	2003	Ori Davidov Havi Murad Ayala Lusky Eric S. Shinwell Brian Reichman Laurence S. Freedman
+	Bayesian Reporting of Clinical Trials	2003	Simon Weeden Laurence S. Freedman Mahesh Parmar
+	Bayesian Reporting of Clinical Trials	2003	Laurence S. Freedman Simon Weeden Mahesh Parmar
+	Small Samples and Ordered Logistic Regression	2003	Havi Murad Anat Fleischman Siegal Sadetzki Orna Geyer Laurence S. Freedman
+ PDF Chat	A simple method for analyzing data from a randomized trial with a missing binary outcome	2003	Stuart G. Baker Laurence S. Freedman
+	Erratum to “Confidence intervals and statistical power of the ‘Validation’ ratio for surrogate or intermediate endpoints”	2002	Laurence S. Freedman
+	Confidence intervals and statistical power of the ‘Validation’ ratio for surrogate or intermediate endpoints	2001	Laurence S. Freedman
+	Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer	2001	Heidi L. Weiss Donald A. Urban William Grizzle Kathleen A. Cronin Laurence S. Freedman Gary J. Kelloff Ronald Lieberman
+	Covariate Measurement Error Adjustment for Matched Case–Control Studies	2001	Lisa M. McShane Douglas N. Midthune Joanne F. Dorgan Laurence S. Freedman Raymond J. Carroll
+	The next 10 years of biostatistics	2000	Laurence S. Freedman
+	What is quantitative significance and is it useful?	1999	Laurence S. Freedman
+	Discussion	1999	Kathleen A. Cronin Laurence S. Freedman R Lieberman Heidi L. Weiss Samuel W. Beenken Gary J. Kelloff
+ PDF Chat	Design Aspects of Calibration Studies in Nutrition, with Analysis of Missing Data in Linear Measurement Error Models	1997	Raymond J. Carroll Laurence S. Freedman David Pee
+	Bayesian Design and Analysis of Two x Two Factorial Clinical Trials	1997	Richard Simon Laurence S. Freedman
+	Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative	1996	Laurence S. Freedman Garnet L. Anderson Victor Kipnis Ross L. Prentice C.Y. Wang Jacques E. Rossouw Janet Wittes David L. DeMets
+ PDF Chat	Bayesian statistical methods	1996	Laurence S. Freedman
+	Interplay between Design and Analysis for Behavioral Intervention Trials with Community as the Unit of Randomization	1995	Sylvan B. Green Donald K. Corle Mitchell H. Gail Steven D. Mark David Pee Laurence S. Freedman Barry I. Graubard William R. Lynn
+	Identifying Which Sets of Parameters are Simultaneously Estimable in an Incomplete Factorial Design	1995	David P. Byar Laurence S. Freedman Agnes M. Herzberg
+	A unified method for monitoring and analysing controlled trials	1994	Jason Grossman Mahesh Parmar David J. Spiegelhalter Laurence S. Freedman
+	The what, why and how of bayesian clinical trials monitoring	1994	Laurence S. Freedman David J. Spiegelhalter Mahesh Parmar
+	Early stopping of prevention trials when multiple outcomes are of interest: A discussion	1994	Sylvan B. Green Laurence S. Freedman
+	The chart trials: Bayesian design and monitoring in practice	1994	Mahesh Parmar David J. Spiegelhalter Laurence S. Freedman
+	Bayesian Approaches to Randomized Trials	1994	David J. Spiegelhalter Laurence S. Freedman Mahesh Parmar
+	Preface	1993	Ted Colton Laurence S. Freedman Tony G. Johnson David Machin
+	Applying Bayesian ideas in drug development and clinical trials	1993	David J. Spiegelhalter Laurence S. Freedman Mahesh Parmar
+	The design of observer agreement studies with binary assessments	1993	Laurence S. Freedman Mahesh Parmar Stuart G. Baker
+	The Impact of Stopping Rules on Heterogeneity of Results in Overviews of Clinical Trials	1992	Michael D. Hughes Laurence S. Freedman Stuart J. Pocock
+	Application of bayesian statistics to decision making during a clinical trial	1992	Laurence S. Freedman David J. Spiegelhalter
+	Statistical validation of intermediate endpoints for chronic diseases	1992	Laurence S. Freedman Barry I. Graubard Arthur Schatzkin
+	Editorial	1992	Ted Colton Laurence S. Freedman Tony G. Johnson David Machin
+	THE AUTHORS REPLY	1991	Laurence S. Freedman Arthur Schatzkin Yohanan Wax
+	Using Replicate Observations in Observer Agreement Studies with Binary Assessments	1991	Stuart G. Baker Laurence S. Freedman Mahesh Parmar
+	Preface	1990	Ted Colton Laurence S. Freedman Tony G. Johnson David Machin
+	Assessing the gain in efficiency due to matching in a community intervention study	1990	Laurence S. Freedman S. B. Green David P. Byar
+ PDF Chat	Statistical Designs for Investigating Several Interventions in the Same Study: Methods for Cancer Prevention Trials	1990	Laurence S. Freedman S. B. Green
+	The effect of partial noncompliance on the power of a clinical trial	1990	Laurence S. Freedman
+	Issues in the design of drug trials for AIDS	1990	Sylvan B. Green Susan S. Ellenberg Dianne M. Finkelstein Alan B. Forsythe Laurence S. Freedman Katherine Freeman Myrto Lefkopoulou David Schoenfeld Rebecca P. Smith
+	Comparison of Bayesian with group sequential methods for monitoring clinical trials	1989	Laurence S. Freedman David J. Spiegelhalter
+	Return to a Note on Screening Regression Equations	1989	Laurence S. Freedman David Pee
+	Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials	1989	Laurence S. Freedman Richard Sylvester David P. Byar
+	Preface	1989	Theodore Colton Laurence S. Freedman Tony G. Johnson David MaChin
+	Improving the quality of data in randomized clinical trials: The compact computer package. Compact steering committee	1988	Clair Chilvers Peter Fayers Laurence S. Freedman R. Mark Greenwood David Machin New Palmer Andrew Westlake
+	Preface	1988	Ted Colton Laurence S. Freedman Tony G. Johnson David Machin
+	A Predictive Approach to Selecting the Size of a Clinical Trial, Based on Subjective Clinical Opinion	1988	David J. Spiegelhalter Laurence S. Freedman
+	Editorial	1988	Ted Colton Laurence S. Freedman Tony G. Johnson
+ PDF Chat	State of the art in comparative cancer clinical trials	1987	Colin B. Begg Stuart J. Pocock Laurence S. Freedman Marvin Zelen
+	preface	1987	Ted Colton Laurence S. Freedman Tony G. Johnson
+	Preface	1987	Ted Colton Laurence S. Freedman Tony G. Johnson
+	Preface	1986	Ted Colton Laurence S. Freedman Tony G. Johnson
+	Monitoring clinical trials: Conditional or predictive power?	1986	David J. Spiegelhalter Laurence S. Freedman Patrick R. Blackburn
+	A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion	1986	David J. Spiegelhalter Laurence S. Freedman
+	Tables of the number of patients required in clinical trials using the logrank test	1986	Laurence S. Freedman
+	Stopping Rules for Clinical Trials Incorporating Clinical Opinion	1984	Laurence S. Freedman D. Lowe Petra Macaskill
+	Stopping rules for clinical trials	1983	Laurence S. Freedman D. Lowe Petra Macaskill
+	The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials	1983	Laurence S. Freedman David J. Spiegelhalter
+	Tables of the number of patients required in clinical trials using the logrank test	1982	Laurence S. Freedman
+	Watson's <i>U</i><sub>N</sub><sup>2</sup> statistic for a discrete distribution	1981	Laurence S. Freedman
+ PDF Chat	The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation.	1979	Laurence S. Freedman
+	Some Comments on the Logrank Test Statistic in Clinical Trial Applications	1979	J. L. Haybittle Laurence S. Freedman
+	Theuse ofa Kolmogorov-Smirnov typestatistic in testing hypotheses aboutseasonal variation	1979	Laurence S. Freedman
+	Allocation of patients to treatment groups in a controlled clinical study	1978	Susan J. White Laurence S. Freedman
+	On the Use of Pocock and Simon's Method for Balancing Treatment Numbers over Prognostic Factors in the Controlled Clinical Trial	1976	Laurence S. Freedman Susan J. White

Common Coauthors

Coauthor	Papers Together
Victor Kipnis	12
David J. Spiegelhalter	11
Raymond J. Carroll	10
Tony G. Johnson	9
Mahesh Parmar	9
Ted Colton	8
Amit Huppert	8
Douglas Midthune	7
Havi Murad	6
Yair Goldberg	6
Micha Mandel	6
Janet A. Tooze	4
David Machin	4
Pamela A. Shaw	4
Stuart G. Baker	4
Ron Milo	4
Liraz Olmer	4
Sharon Alroy‐Preis	4
Nachman Ash	4
Omri Bodenheimer	4
Yinon M. Bar-On	4
Kevin W. Dodd	4
David Pee	3
Arnona Ziv	3
Ronen Fluss	3
Sylvan B. Green	3
Rachel Dankner	3
Ilya Novikov	3
Paul Gustafson	3
David P. Byar	3
Susan J. White	2
Susan M. Krebs‐Smith	2
Heidi L. Weiss	2
Stuart J. Pocock	2
Nirit Agay	2
Ilya Novikov	2
Patricia M. Guenther	2
Kathleen A. Cronin	2
Ross L. Prentice	2
Helmut Küchenhoff	2
Rami Yaari	2
Veronika Deffner	2
Barry I. Graubard	2
Daniela Sotres‐Alvarez	2
Ruth H. Keogh	2
Yonatan Woodbridge	2
Petra Macaskill	2
Arthur Schatzkin	2
Simon Weeden	2
Dennis W. Buckman	2

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design	1976	Richard Peto Malcolm C. Pike P. Armitage N. E. Breslow D. R. Cox S V Howard Nathan Mantel Klim McPherson Julian Peto Peter G. Smith	10
+	The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials	1983	Laurence S. Freedman David J. Spiegelhalter	9
+	Clinical Trials: A Practical Approach.	1984	Ira Hill Stuart J. Pocock	8
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming	7
+	Monitoring clinical trials: Conditional or predictive power?	1986	David J. Spiegelhalter Laurence S. Freedman Patrick R. Blackburn	6
+	Stopping Rules for Clinical Trials Incorporating Clinical Opinion	1984	Laurence S. Freedman D. Lowe Petra Macaskill	6
+	Interim Analyses in Randomized Clinical Trials: Ramifications and Guidelines for Practitioners	1987	Nancy L. Geller Stuart J. Pocock	6
+	Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial	1975	Stuart J. Pocock Richard Simon	6
+	Measurement Error Models	1988	Leonard A. Stefanski Wayne A. Fuller John Wiley	6
+	Introduction to sample size determination and power analysis for clinical trials	1981	John M. Lachin	5
+	The Design and Analysis of Sequential Clinical Trials.	1983	R. J. Prescott John Whitehead	5
+	Group sequential methods in the design and analysis of clinical trials	1977	Stuart J. Pocock	5
+	Covariate measurement errors and parameter estimation in a failure time regression model	1982	Ross L. Prentice	5
+	Comparison of Bayesian with group sequential methods for monitoring clinical trials	1989	Laurence S. Freedman David J. Spiegelhalter	5
+	An aid to data monitoring in long-term clinical trials	1982	Max Halperin K. K. Gordon Lan James H. Ware Norman J. Johnson David L. DeMets	5
+	Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples	1977	Richard Peto M. C. Pike P. Armitage N. E. Breslow DUNCAN COX S V Howard Nathan Mantel Kerri McPherson Julian Peto Peter G. Smith	5
+	Approximate Quasi-likelihood Estimation in Models with Surrogate Predictors	1990	Raymond J. Carroll Leonard A. Stefanski	4
+	Statistics and Medical Experimentation	1975	Paul Meier	4
+	The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time	1981	Anastasios A. Tsiatis	4
+	Repeated Significance Tests on Accumulating Data	1969	P. Armitage C. K. McPherson Beverley Charles Rowe	4
+	Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables	1977	Charles W. Dunnett Michael Gent	4
+	Bayesian Approaches to Randomized Trials	1994	David J. Spiegelhalter Laurence S. Freedman Mahesh Parmar	4
+	A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion	1986	David J. Spiegelhalter Laurence S. Freedman	4
+ PDF Chat	Multiple-imputation for measurement-error correction	2006	Stephen R. Cole Haitao Chu Sander Greenland	4
+ PDF Chat	A new multivariate measurement error model with zero-inflated dietary data, and its application to dietary assessment	2011	Saijuan Zhang Raymond J. Carroll Douglas Midthune Patricia M. Guenther Susan M. Krebs‐Smith Victor Kipnis Kevin W. Dodd Dennis W. Buckman Janet A. Tooze Laurence S. Freedman	4
+	Stopping rules for clinical trials	1983	Laurence S. Freedman D. Lowe Petra Macaskill	4
+	A New Method for Dealing with Measurement Error in Explanatory Variables of Regression Models	2004	Laurence S. Freedman Vitaly Fainberg Victor Kipnis Douglas Midthune Raymond J. Carroll	4
+	The chart trials: Bayesian design and monitoring in practice	1994	Mahesh Parmar David J. Spiegelhalter Laurence S. Freedman	4
+	A Bayesian Test of Some Classical Hypotheses—With Applications to Sequential Clinical Trials	1966	Jerome Cornfield	3
+ PDF Chat	A comparison of regression calibration, moment reconstruction and imputation for adjusting for covariate measurement error in regression	2008	Laurence S. Freedman Douglas Midthune Raymond J. Carroll Victor Kipnis	3
+	Measurement Error and Misclassification in Statistics and Epidemiology: Impacts and Bayesian Adjustments	2003	Paul Gustafson	3
+ PDF Chat	Maximum likelihood, multiple imputation and regression calibration for measurement error adjustment	2008	Karen Messer Loki Natarajan	3
+	Correction of logistic regression relative risk estimates and confidence intervals for systematic within‐person measurement error	1989	Bernard Rosner Walter C. Willett Donna Spiegelman	3
+ PDF Chat	Conditional scores and optimal scores for generalized linear measurement-error models	1987	Leonard A. Stefanski Raymond J. Carroll	3
+	Qualms about Bootstrap Confidence Intervals	1985	Nathaniel Schenker	3
+	On the Use of Pocock and Simon's Method for Balancing Treatment Numbers over Prognostic Factors in the Controlled Clinical Trial	1976	Laurence S. Freedman Susan J. White	3
+	“Proving the null hypothesis” in clinical trials	1982	William C. Blackwelder	3
+	KSTAGE: An interactive computer program for designing phase II clinical trials using predictive probability	1982	E. Neely Atkinson Barry W. Brown Jay Herson	3
+	Optimum biased coin designs for sequential clinical trials with prognostic factors	1982	Anthony C. Atkinson	3
+	Discrete sequential boundaries for clinical trials	1983	K. K. Gordon Lan David L. DeMets	3
+	The what, why and how of bayesian clinical trials monitoring	1994	Laurence S. Freedman David J. Spiegelhalter Mahesh Parmar	3
+	Statistics: The Problem of Examining Accumulating Data More Than Once	1974	Klim McPherson	3
+	CORRECTION OF LOGISTIC REGRESSION RELATIVE RISK ESTIMATES AND CONFIDENCE INTERVALS FOR MEASUREMENT ERROR: THE CASE OF MULTIPLE COVARIATES MEASURED WITH ERROR	1990	Bernard Rosner Donna Spiegelman Walter C. Willett	3
+	On choosing the number of interim analyses in clinical trials	1982	Klim McPherson	3
+ PDF Chat	Estimating Usual Dietary Intake Distributions: Adjusting for Measurement Error and Nonnormality in 24‐Hour Food Intake Data	1997	Sarah M. Nusser Wayne A. Fuller Patricia M. Guenther	3
+	Correction of Logistic Regression Relative Risk Estimates and Confidence Intervals for Random Within-Person Measurement Error	1992	Bernard Rosner Donna Spiegelman Walter C. Willett	3
+	Inference and decision in clinical trials	1989	Peter Armitage	3
+	Goodness-of-Fit Tests for Discrete Data: A Review and an Application to a Health Impairment Scale	1977	Susan D. Horn	3
+	Statistical controversies in the design of clinical trials—Some personal views	1980	Byron W. Brown	3
+	Statistical Analysis With Missing Data	1989	Maureen Lahiff Roderick J. A. Little Donald B. Rubin	3